Based on interviews, record review, and Review of Mosby's 2017 Nursing Drug Reference Book, the facility failed to ensure Resident Identifier (RI) 9's Apixaban (Eliquis) was not resumed on 04/10/2025 at 8:00 PM when RI #9 had an actively bleeding surgical incision and abnormal laboratory (lab) blood values. On 04/07/2025, a change of condition was noted in RI #9's medical record related to bleeding from a surgical incision. Certified Registered Nurse Practitioner (CRNP) #75 was notified, and orders were obtained to hold RI #9's Eliquis for three days. …
F757 citations in Alabama
Unnecessary drugs · Pharmacy Service Deficiencies
Ensure each resident’s drug regimen must be free from unnecessary drugs.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Alabama cites F757 more often than its own record predicts
1.25 times the share F757 takes of citations nationally.
Of every deficiency written in Alabama in 2025, this is the portion that was F757.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Alabama surveyors wrote
F757 findings written in Alabama, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
Based on interview, record review, and facility policy review, the facility failed to ensure nursing staff did not administer glimepiride (an oral hypoglycemic medication used to lower blood glucose levels) with documented low blood glucose levels ranging from 32 mg/dL (milligrams/ deciliter) to 44 mg/dL and poor oral intake for one of one resident (Resident (R) 12) reviewed for unnecessary drugs of 29 sample residents. This deficient practice placed R12 at risk for, and resulted in, worsening hypoglycemia requiring hospitalization.Findings include:Review of R12's Face Sheet located in the Resident tab of the electronic medical record (EMR) indicated admission on [DATE] with diagnoses including type two diabetes mellitus and multiple sclerosis.Review of R12's quarterly Minimum Data Set… …
The short window
Recent years
| Year | Share of Alabama citations | vs expected |
|---|---|---|
| 2023 | 0.52% | 0.65× |
| 2025 | 0.99% | 1.25× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else Alabama surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction